SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cryogenic OGS surges on bagging purchase order from Endress and Hauser

31 Jul 2025 Evaluate

Cryogenic OGS is currently trading at Rs. 138.00, up by 6.10 points or 4.62% from its previous closing of Rs. 131.90 on the BSE.

The scrip opened at Rs. 128.01 and has touched a high and low of Rs. 138.50 and Rs. 126.26 respectively. So far 177000 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 150.00 on 28-Jul-2025 and a 52 week low of Rs. 89.30 on 10-Jul-2025.

Last one week high and low of the scrip stood at Rs. 150.00 and Rs. 125.06 respectively. The current market cap of the company is Rs. 197.06 crore.

The promoters holding in the company stood at 73.53%, while Institutions and Non-Institutions held 11.87% and 14.60% respectively.

Cryogenic OGS has bagged a purchase order from Endress and Hauser of Rs 1.28 crore (Excluding Taxes). This order includes a complete range of its terminal automation products such as air eliminators, strainer cum air eliminators, prover tanks, master meter trolleys, additive dosing blocks and skids, along with related spares. It adds to the company’s growing supply record in terminal automation systems and reflects the continued use of its products across multiple terminals. The said order is expected to be completed within 12 weeks. 

Cryogenic OGS is engaged in fabrication and assembling of gas metering skid and meter run, chemical and additive injection skid, strainer cum air and vapor eliminator, design fabrication and testing of strainer, bulk air eliminator, pressure vessels, LPG vapor eliminator, prover tank, etc.

Cryogenic OGS Share Price

174.10 1.10 (0.64%)
21-Apr-2026 11:47 View Price Chart
Peers
Company Name CMP
BHEL 330.60
Thermax 4050.00
Kirloskar Oil Eng 1659.40
Skipper 465.25
GMM Pfaudler 924.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×